Guest Editorial AACR conference examines how societal framework of racism drives cancer disparities October 16, 2020Vol.46 No.39By Steven R. Patierno
NCI Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act October 16, 2020Vol.46 No.39By Alexandria Carolan
Karen Knudsen’s AACI presidential initiative: Reduce cancer disparities across North America October 16, 2020Vol.46 No.39By Matthew Bin Han Ong
Drugs & Targets Expanded access eRequest app allows physicians to submit EA requests online September 25, 2020Vol.46 No.36
Drugs & Targets FDA accepts for priority review application for anti-BCMA CAR T-cell therapy idecabtagene vicleucel (Ide-cel, bb2121) September 25, 2020Vol.46 No.36
Drugs & Targets Agenus begins rolling BLA submission of balstilimab to FDA for treatment of recurrent/metastatic cervical cancer September 25, 2020Vol.46 No.36
Drugs & Targets FDA accepts sNDA for Xalkori for pediatric ALK-positive anaplastic large cell lymphoma September 25, 2020Vol.46 No.36
Drugs & Targets EMA’s CHMP issues positive opinion for Zejula in ovarian cancer indication September 25, 2020Vol.46 No.36
Clinical Roundup Study: Black women with breast cancer experience delayed, longer treatment than whites September 25, 2020Vol.46 No.36
Clinical Roundup Fred Hutch-led clinical trial shows new smartphone app helps smokers quit September 25, 2020Vol.46 No.36
